A Retrospective, Observational study to evaluate the treatment persistence of basal insulin (insulin glargine or insulin detemir) and its impact on A1c levels in patients with Type II Diabetes Mellitus

Trial Profile

A Retrospective, Observational study to evaluate the treatment persistence of basal insulin (insulin glargine or insulin detemir) and its impact on A1c levels in patients with Type II Diabetes Mellitus

Completed
Phase of Trial: Phase IV

Latest Information Update: 20 Jul 2017

At a glance

  • Drugs Insulin detemir (Primary) ; Insulin glargine (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Jul 2017 New trial record
    • 13 Jun 2017 Results presented at the 77th Annual Scientific Sessions of the American Diabetes Association
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top